| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |